Bronchodilator effect of Ipraterol on methacholine-induced bronchoconstriction in asthmatic patients.
J Med Assoc Thai. 2011 Feb;94 Suppl 1:S66-71
Authors: Maneechotesuwan K, Suthamsmai T, Ratanasaenglert K, Pipopsuthipaiboon S
The addition of ipratropium, a synthetic cholinergic antagonist, to beta2-agonist therapy provides an additive improvement in adult with acute severe asthma and COPD because of increased vagal tone in the airways. We asked whether ipratropium in combination with fenoterol (Ipraterol) improved pulmonary function in comparison with original Berodual.
PMID: 21728272 [PubMed – in process]
View full post on pubmed: asthma
